Sachin M. Mendhi
Research Subjects
Sachin M. Mendhi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Kuldeep Vinchurkar
Affiliated to Savitribai Phule Pune University (SPPU, Pune)
2 shared publications Amruta Shete
1 shared publicationKrutika Sawarkar
1 shared publication- Pooja Vilas Nagime
Center of Excellence in Innovative Biotechnology for Sustainable Utilization of Bioresources, Faculty of Agro-Industry, Prince of Songkla University, Hat Yai, Thailand
1 shared publication Sachin S. Mali
1 shared publication- Sheetal Mane
School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore, Madhya Pradesh, India
1 shared publication
Latest Publications
- 29 June 2026
- Published by Bentham Science Publishers Ltd. in Pharmaceutical Nanotechnology
- Vol. 14, 1-13
Advancing Cancer Therapy: Nano-Therapeutics for Precision Targeting of the Tumor Microenvironment
Cancer remains one of the most challenging diseases to treat effectively, primarily due to the complex and adaptive nature of the tumour microenvironment. Traditional therapies often fail to target the TME adequately, leading to resistance and relapse. Recent advancements in nanotechnology have opened new avenues for targeted cancer therapy, offering innovative solutions to overcome these challenges. This review provides a comprehensive overview of nano-therapeutics designed to target the TME, highlighting their mechanisms, current progress, and prospects. By emphasizing the relationship between nanotherapeutics and different TME constituents, such as immune cells, stromal cells, and extracellular matrix, we want to clarify how these innovative techniques might improve therapeutic efficacy and reduce side effects. The potential of combining nano-therapeutics with conventional treatments is also explored, emphasizing a multi-faceted strategy in the fight against cancer.
- 29 June 2026
- Published by Bentham Science Publishers Ltd. in Pharmaceutical Nanotechnology
- Vol. 14, 1-13
Advancing Cancer Therapy: Nano-Therapeutics for Precision Targeting of the Tumor Microenvironment
Cancer remains one of the most challenging diseases to treat effectively, primarily due to the complex and adaptive nature of the tumour microenvironment. Traditional therapies often fail to target the TME adequately, leading to resistance and relapse. Recent advancements in nanotechnology have opened new avenues for targeted cancer therapy, offering innovative solutions to overcome these challenges. This review provides a comprehensive overview of nano-therapeutics designed to target the TME, highlighting their mechanisms, current progress, and prospects. By emphasizing the relationship between nanotherapeutics and different TME constituents, such as immune cells, stromal cells, and extracellular matrix, we want to clarify how these innovative techniques might improve therapeutic efficacy and reduce side effects. The potential of combining nano-therapeutics with conventional treatments is also explored, emphasizing a multi-faceted strategy in the fight against cancer.
- Open Access
- 1 June 2025
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (3) , 225-234
Smart healthcare: Artificial intelligences impact on drug development and patient care
- 1 June 2025
- Published by KEAI Publishing in Intelligent Pharmacy
- Vol. 3 (3) , 225-234
Open AccessSmart healthcare: Artificial intelligences impact on drug development and patient care